Benaroya Research Institute's third annual immunology symposium, New Horizons in Immunity and Disease, will take place on Tuesday, May 5, 2026. Due to strong interest and enthusiastic support from the immunology community, we’re relocating this year’s event to Bell Harbor International Conference Center in Seattle, a larger venue that will better accommodate our growing audience.
We’re excited to once again bring together leading voices from the local and national immunology research community for a day of collaboration, discovery, discussion and connection. Building on two years of full houses, dynamic presentations, and meaningful dialogue, this year’s symposium is set to continue that momentum.
Thank you for your interest in BRI’s 2026 Immunology Symposium: New Horizons in Immunity and Disease. We are currently at capacity for the event and registration is closed. If you would like to be placed on the waitlist, please email communications@benaroyaresearch.org and we will contact you if space is available.
Please contact BRI's marketing and communications team via email with any questions.
BRI Immunology Symposium Speakers
The program features two standout keynote speakers, Jay Shendure, MD, PhD, and Phil Greenberg, MD, alongside a strong lineup of nationally and locally recognized researchers from institutions including BRI, the University of Washington, and the Allen Institute for Immunology. Additional speakers and the full agenda will be announced in the coming months. Registration is now open.
BRI Thanks Our Generous Sponsors
Thank you to our partners, supporters and collaborators. Please stop by the booth area at the symposium to connect.
News
Seattle Children’s Research Institute, Benaroya Research Institute at Virginia Mason Franciscan Health, and GentiBio Highlight Long Standing Scientific Collaboration Advancing GNTI 122 Into the Clinic
Read More
University of Washington 2026 Husky 100
Read More ➡
New Study Links Noncoding DNA Genetic Variants to Root Causes of Rheumatoid Arthritis
Read More
Featured Publications
Atlas of HIV cis-regulatory elements reveals extensive transcriptional variation across clades, isolates, and within individuals
bioRxiv
DYRK1A and Parkinson's disease, facts and hypotheses
Neurobiol Dis
A fast way to lose antibodies
Immunity
Defects in CD8+ T cell suppression by Foxp3-ΔE2 expressing regulatory T cells
bioRxiv
Association of epigenetic trajectory with development of clinical rheumatoid arthritis in anti-citrullinated protein antibody positive individuals: Targeting Immune Responses for Prevention of Rheumatoid Arthritis (TIP-RA)
Arthritis Rheumatol
